WallStreetZenWallStreetZen

NASDAQ: ALLK
Allakos Inc Stock Forecast, Predictions & Price Target

Analyst price target for ALLK

Based on 3 analysts offering 12 month price targets for Allakos Inc.
Min Forecast
$1.00+16.28%
Avg Forecast
$1.83+113.14%
Max Forecast
$3.00+248.84%

Should I buy or sell ALLK stock?

Based on 3 analysts offering ratings for Allakos Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their ALLK stock forecasts and price targets.

ALLK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-26
lockedlocked$00.00+00.00%2024-01-17
lockedlocked$00.00+00.00%2024-01-17

1 of 1

Forecast return on equity

Is ALLK forecast to generate an efficient return?
Company
-63.86%
Industry
73.55%
Market
80.54%
ALLK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALLK forecast to generate an efficient return on assets?
Company
-37.45%
Industry
31.45%
ALLK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALLK earnings per share forecast

What is ALLK's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.24
Avg 2 year Forecast
-$0.69
Avg 3 year Forecast
-$0.68

ALLK revenue forecast

What is ALLK's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$59.9M
Avg 2 year Forecast
$378.0M
Avg 3 year Forecast
$479.4M

ALLK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALLK$0.86$1.83+113.14%Hold
SPRO$1.42$7.00+394.70%Buy
ANTX$2.58$5.00+93.80%Hold
MRNS$1.37$10.50+666.42%Buy
DBVT$0.80$10.00+1,150.00%Buy

Allakos Stock Forecast FAQ

Is Allakos Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ALLK) stock is to Hold ALLK stock.

Out of 3 analysts, 0 (0%) are recommending ALLK as a Strong Buy, 1 (33.33%) are recommending ALLK as a Buy, 1 (33.33%) are recommending ALLK as a Hold, 0 (0%) are recommending ALLK as a Sell, and 1 (33.33%) are recommending ALLK as a Strong Sell.

If you're new to stock investing, here's how to buy Allakos stock.

What is ALLK's earnings growth forecast for 2024-2026?

(NASDAQ: ALLK) Allakos's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.02%.

Allakos's earnings in 2024 is -$214,443,000.On average, 3 Wall Street analysts forecast ALLK's earnings for 2024 to be -$110,087,345, with the lowest ALLK earnings forecast at -$122,191,374, and the highest ALLK earnings forecast at -$95,628,032. On average, 4 Wall Street analysts forecast ALLK's earnings for 2025 to be -$60,652,965, with the lowest ALLK earnings forecast at -$85,002,695, and the highest ALLK earnings forecast at -$45,157,682.

In 2026, ALLK is forecast to generate -$59,918,046 in earnings, with the lowest earnings forecast at -$89,429,919 and the highest earnings forecast at -$42,501,348.

What is ALLK's revenue growth forecast for 2027-2029?

(NASDAQ: ALLK) Allakos's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.

Allakos's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast ALLK's revenue for 2027 to be $5,306,913,049, with the lowest ALLK revenue forecast at $3,037,075,458, and the highest ALLK revenue forecast at $7,576,750,640. On average, 1 Wall Street analysts forecast ALLK's revenue for 2028 to be $33,465,383,948, with the lowest ALLK revenue forecast at $33,465,383,948, and the highest ALLK revenue forecast at $33,465,383,948.

In 2029, ALLK is forecast to generate $42,444,236,334 in revenue, with the lowest revenue forecast at $1,965,687,323 and the highest revenue forecast at $82,922,785,346.

What is ALLK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ALLK) forecast ROA is -37.45%, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is ALLK's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ALLK price target, the average ALLK price target is $1.83, with the highest ALLK stock price forecast at $3.00 and the lowest ALLK stock price forecast at $1.00.

On average, Wall Street analysts predict that Allakos's share price could reach $1.83 by Jun 26, 2025. The average Allakos stock price prediction forecasts a potential upside of 113.14% from the current ALLK share price of $0.86.

What is ALLK's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ALLK) Allakos's current Earnings Per Share (EPS) is -$2.46. On average, analysts forecast that ALLK's EPS will be -$1.24 for 2024, with the lowest EPS forecast at -$1.38, and the highest EPS forecast at -$1.08. On average, analysts forecast that ALLK's EPS will be -$0.69 for 2025, with the lowest EPS forecast at -$0.96, and the highest EPS forecast at -$0.51. In 2026, ALLK's EPS is forecast to hit -$0.68 (min: -$1.01, max: -$0.48).

What is ALLK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ALLK) forecast ROE is -63.86%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.